HIV Infections: all 4,342 studies
Page 26 of 44. Open to participants first (242), then studies with results posted, then the rest; newest registration first within each.
- Examining the Role of Genetics in Determining the Immune Response to an HIV Vaccine in HIV-Uninfected Adult TwinsCompletedNCT01054872Phase 1
- HIV Treatment and CVD EventsCompletedNCT01054638
- TMC114-TiDP3-C182 - A Study to Compare the Oral Bioavailability of a 800 mg Prototype Tablet Formulation of Darunivar (DRV) to That of the 400 mg Commercial Tablet Formulation in the Presence of Low Dose Ritonavir, Under Fasted and Fed ConditionsCompletedNCT01052883Phase 1
- Notification of Donors With Positive Microbiology MarkersCompletedNCT01050881
- Pre-Exposure Prophylaxis Using TMC278LATerminatedNCT01049932Phase 1/2
- Lopinavir/Ritonavir or Efavirenz as First-line Antiretroviral TherapyStatus unknownNCT01049685Phase 4
- Cell Phone Reminders InterventionCompletedNCT01049568Not applicable
- Impact of Maraviroc on the Immune Function in HIV-1 Infected Subjects Receiving Immunisation With Novel AntigensTerminatedNCT01049204Phase 4
- Preventative Misconception InterventionCompletedNCT01049139Not applicable
- Observational Study of Blood Treated With CytolinCompletedNCT01048372
- Pharmacokinetics (PK) Study of Once Daily Darunavir/Ritonavir and Twice and Once Daily Raltegravir in HIV-infected SubjectsCompletedNCT01047995Phase 1
- Drug Interactions Between Echinacea Purpurea and Darunavir/RitonavirCompletedNCT01046890Phase 4
- A Pilot Study of Kaletra and Intelence Tablets in Naive SubjectsCompletedNCT01045369Phase 4
- A Study To Investigate The Clearance Of PF-04776548 From The Body Following A Very Low (Micro) Dose Of The Compound Using A Low Level Of Radiotracer To Help Quantify Expected Low Concentrations Of PF-04776548 In The BodyCompletedNCT01045317Phase 1
- Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected PatientsCompletedNCT01044654Phase 1
- Isentress Re-examination Study (MK-0518-115)CompletedNCT01042808
- A Trial to Compare Raltegravir Versus Nevirapine as Anchor Drug for HIV+ Chinese IDUs on Methadone MaintenanceStatus unknownNCT01042652Not applicable
- Evaluation of the Cellular Pharmacology of Tenofovir and Emtricitabine According to HIV Infection StatusCompletedNCT01040091Phase 1
- Accelerated Aging, HIV Infection, Antiretroviral TherapiesCompletedNCT01038999
- Residual Replication of HIV-1 in the Gut Associated Lymphoid Tissue (GALT) of Patients on Highly Active Antiretroviral Therapy (HAART): the ANRS EP 44 StudyCompletedNCT01038401Not applicable
- Medications for Chronic HIV: Education and CollaborationCompletedNCT01038076Not applicable
- Optimisation of Primary HIV1 Infection Treatment(ANRS 147 OPTIPRIM)CompletedNCT01033760Phase 3
- Evaluation of the Performance of Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 Rapid TestCompletedNCT01032902
- Immunogenicity, Safety, and Tolerability of MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With HIV-1 InfectionCompletedNCT01032408Phase 3
- Analysis of Changes in Adipose Tissue of Patients With Lipoatrophy HIV Infection Treated With Nucleoside Thymidine, After Switching to Monotherapy With Lopinavir / RitonavirTerminatedNCT01031849Phase 4
- TMC278-TiDP15-C158 - A Study to Examine the Safety, Tolerability and Pharmacokinetics of a Single Dose or Three Successive Doses of Intramuscularly (IM) Injected Long Acting Formulation of TMC278CompletedNCT01031589Phase 1
- A Study to Assess Relative Bioavailability and Food Effect of New Formulations of GSK2248761CompletedNCT01031472Phase 1
- Observational Study on Anti-Tat Immune Response in HIV-1-infected Asymptomatic Adult SubjectsCompletedNCT01029548
- Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected AdultsCompletedNCT01029249
- Comparison of Concentration-time Course of Plasma and Intracellular Raltegravir in Healthy VolunteersCompletedNCT01027182Phase 1
- A Study to Assess the Long-term Efficacy (24 Weeks) of MPC-4326 in Combination With a 2-3 Drug OBR Relative to the Efficacy of a 3-4 Drug ARV Regimen in Treatment Experienced HIV-1 Infected Subjects Who Are Failing Current Antiretroviral TherapyTerminatedNCT01026727Phase 2
- Observational Study of the Therapeutic Study of Recombinant HIV-1 TATCompletedNCT01024595
- Observational Study on Anti-Tat Immune Response in HIV-1-infected HAART-treated Adult SubjectsCompletedNCT01024556
- Vaccine Responses to Influenza A H1N1/09 Immunization in High-risk PatientsCompletedNCT01022905Phase 4
- Raltegravir in Patients With End Stage Liver Disease and in Transplant RecipientsCompletedNCT01022476Phase 1/2
- Effect of HIV Infection and Highly Active Antiretroviral Treatment (HAART) on Bone HomeostasisCompletedNCT01020045
- Computerized Counseling to Promote Positive Prevention and HIV Health in KenyaCompletedNCT01015989Not applicable
- Cardiovascular Risk Evaluation and Antiretrovirals in HIVCompletedNCT01015092
- A Spanish-Language Intervention to Enhance Routine HIV Patient Care Delivery [CARE+ Spanish]CompletedNCT01013935Not applicable
- Clinical Trial to Evaluate the Immunogenicity and Safety of an Adjuvanted A(H1N1)v Influenza Vaccine and a Non-adjuvanted A(H1N1)v Influenza Vaccine in HIV-infected Patients (ANRS 151 Hifluvac)CompletedNCT01008813Phase 2
- Retreatment With High Doses of pegIFN Alfa-2a and Ribavirin of Previous Nonresponders HIV-coinfected Patients With Cirrhosis Due to HCV 1-4CompletedNCT01006031Phase 2/3
- Adherence-Suppression-Resistance Relationships for Atripla Compared to Historical Antiretroviral RegimensCompletedNCT01006005
- Reassessment of the Nutritional Status in Thai Orphans Living With HIV in a Family Style CommunityCompletedNCT01002612
- Pilot Study of Text Message Reminders to Improve HIV Medication Adherence in BotswanaCompletedNCT01001741Not applicable
- Integrating Family Planning Services Into HIV Care and Treatment in Nyanza Province, KenyaCompletedNCT01001507Not applicable
- TMC278-TiDP6-C154: Evaluation of the Possible Influence of Omeprazole Intake - and the pH Increase in the Stomach Triggered by Omeprazole Intake - on the Blood Levels of TMC278 in Healthy VolunteersCompletedNCT01001247Phase 1
- Conjugate And Polysaccharide Vaccines Compared With Polysaccharide Vaccine In Hiv-Infected AdultsStatus unknownNCT00999739Phase 3
- ADHEPTA Study: Adherence Questionnaire in Hepatitis CCompletedNCT00998621
- Immunogenicity of Novel H1N1 Vaccination Among HIV-Infected Compared to HIV-Uninfected PersonsCompletedNCT00996970
- Pilot Study to Compare the Pharmacokinetics Parameters in Plasma and Intracellular of Raltegravir Administered Once a Day in Adult Patients Infected With HIVCompletedNCT00995241Phase 4
- The Women's HIV SeroIncidence Study (ISIS)CompletedNCT00995176
- Clinical Study to Evaluate the Efficacy and Safety of Lopinavir/Ritonavir Monotherapy Versus Darunavir/Ritonavir Monotherapies as Simplification Switching Strategies of PI/NNRTI-Triple Therapy Based-RegimensCompletedNCT00994344Phase 4
- The Shang Ring: A Novel Male Circumcision Device for HIV PreventionCompletedNCT00993811Phase 1
- A Treatment Access Program To Provide Maraviroc To Eligible Adult Patients Completing A4001050 Study Until Commercial Availability Of Maraviroc (Celsentri) In IndiaNo longer availableNCT00992654
- Safety of and Immune Response to the PENNVAX-B DNA Vaccine With and Without IL-12 in HIV-uninfected AdultsCompletedNCT00991354Phase 1
- Redirected High Affinity Gag-Specific Autologous T Cells for HIV Gene TherapyCompletedNCT00991224Phase 1
- QoL and Adherence to One-pill Once-a-day HAARTCompletedNCT00990600Phase 3
- Using Heavy Water to Study Cell Dynamics in Parkinson's DiseaseStatus unknownNCT00990379
- Preliminary Study of Early, Primary HIV Infection in a High Risk CohortCompletedNCT00989144
- Europe-Africa Research Network for Evaluation of Second-line TherapyCompletedNCT00988039Phase 3
- HIV Testing in the Emergency Department at Baystate Medical Center: A Pilot ProgramCompletedNCT00987194
- Pharmacokinetics of Lamivudine at Two Different DosesCompletedNCT00985647Phase 1/2
- Rectal Microbicide Safety and Acceptability Trial of Topically Applied Tenofovir Compared With Oral TabletCompletedNCT00984971Phase 1
- Safety and Immunogenicity Study of Candidate HIV-1 Vaccine Given to Healthy Infants Born to HIV-1/2-uninfected MothersCompletedNCT00982579Phase 1
- The St. Marys and The Mater Switch StudyTerminatedNCT00981773Phase 4
- Safety and Immunogenicity Study of Candidate HIV-1 Vaccine Given to Healthy Infants Born to HIV-1-infected MothersStatus unknownNCT00981695Phase 1/2
- Pilot Assessment of Lopinavir/Ritonavir and MaravirocTerminatedNCT00981318Phase 4
- Profile of HIV Seropositive PatientsCompletedNCT00981279
- Immune-based Therapy Pilot Study for the Treatment of Primary HIV Infection (PHI-IMD).CompletedNCT00979706Phase 4
- IMPAACT P1058A: Pharmacokinetic Effects of New Antiretroviral Drugs on Children, Adolescents and Young AdultsCompletedNCT00977756
- Interaction Between Fosamprenavir/Ritonavir and a Single-dose Olanzapine (FORZA)CompletedNCT00977301Phase 1
- The Effect of Combination of Traditional Chinese Medicine (TCM) and Highly Active Antiretroviral Therapy (HAART) on Immune Reconstitution of HIV/AIDS PatientsStatus unknownNCT00974519Not applicable
- Research on Effect of Traditional Chinese Medicine (TCM) on Immune Reconstitution of HIV/AIDS Patients After Highly Active Antiretroviral Therapy (HAART)Status unknownNCT00974454Not applicable
- Clinical Trials on the Effect of Immunity 1 (Fuzheng 1) on Immune Reconstitution of HIV PatientsStatus unknownNCT00974285Not applicable
- Prevalence of Sexually Transmitted Infections (STIs) in HIV-infected PatientsCompletedNCT00973466
- Mentor Mothers: A Sustainable Family Intervention in South African TownshipsCompletedNCT00972699Phase 2
- Trial Embedded in an Electronic Personal Medical Health RecordsCompletedNCT00972348Not applicable
- Infant Male Circumcision in Gaborone, Botswana, and Surrounding Areas: Feasibility, Safety and AcceptabilityCompletedNCT00971958Not applicable
- A Pilot Study of Pre-Exposure Prophylaxis (PrEP) to Evaluate Safety, Acceptability, and Adherence in At-Risk Populations in Kenya, AfricaCompletedNCT00971230Phase 1/2
- Immune Response After Stem Cell Transplant in HIV-Positive Patients With Hematologic CancerCompletedNCT00968630Phase 2
- Internet-based HIV/STI Prevention for Young MSM Receiving HIV TestingCompletedNCT00968188Not applicable
- Switching the Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) or Protease Inhibitor (PI) to Maraviroc in HIV SubjectsCompletedNCT00966329Phase 4
- CD4 Cell Recovery in HIV-1 Patients Comparing 2 Treatment RegimesCompletedNCT00966160Phase 3
- TMC114-C201: A Study to Determine the Antiviral Activity of TMC114 in Patients With Multiple Protease Inhibitor (PI) Resistant Human Immunodeficiency Virus (HIV) StrainsCompletedNCT00964327Phase 2
- Reducing HIV Risks in African American TeensCompletedNCT00963963Not applicable
- Safety of and Immune Response to Prime/Boost Vaccine Regimens in Healthy, HIV-1 Uninfected, Ad5 Seronegative AdultsCompletedNCT00961883Phase 1
- Assessing HIV-Related Oral Mucosal Disease and Using Saliva to Measure Viral LoadCompletedNCT00959413
- Evaluation of Effectiveness of Pharmaceutical Care on the Adherence of HIV-Positive Patients to Antiretroviral TherapyCompletedNCT00959361Not applicable
- Faster Identification of TB and Evaluation of Drug Resistance in HIV-infected PeopleCompletedNCT00959088
- Raltegravir Switch for Toxicity or Adverse EventsCompletedNCT00958100Phase 2
- Immune Response to an HIV DNA Plasmid Vaccine Prime Followed by Adenovirus Boost in HIV-uninfected IndividualsCompletedNCT00955006Phase 1
- Genotypic Resistant HIV Strains in TaiwanStatus unknownNCT00954863
- Accuracy of the Pima™ CD4 Test for Enumeration of CD4+ T-Cell CountsWithdrawnNCT00951795
- Safety and Efficacy of ADAPTAVIR's Ability to Eliminate Treatment-Resistant Infectious Virus in Peripheral Blood Mononuclear Cells (PBMCs)Status unknownNCT00951743Phase 2
- Feasibility Study of a Multi-Component Intervention for Black Men Who Have Sex With MenCompletedNCT00951249Not applicable
- Computerized HIV/Sexually Transmitted Disease (STD) Prevention ProgramCompletedNCT00947947Phase 2
- Evaluation of a Lopinavir/Ritonavir Monotherapy vs a Triple Therapy as Maintenance Regimens in HIV-1 Infected PatientsCompletedNCT00946595Phase 2/3
- Preparing for Adolescent HIV Vaccine Trials in South Africa:Status unknownNCT00944879
- Evaluation of Maraviroc Intensification in HIV Infected Patients With Insufficient Immune RestorationCompletedNCT00944541Phase 2
- Effect of Antacids on the Pharmacokinetics of RaltegravirCompletedNCT00944307Phase 1